Shilpa Medicare receives USFDA approval for Azacitidine Injection

Shilpa Medicare has received an approval from the United States Food & Drug Administration (USFDA) for Azacitidine - Injection ANDA of SEZ Formulations Facility situated at Jadcherla, near Hyderabad.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.